Brandt Gary E L, Schmidt Matthew D, Prisinzano Thomas E, Blagg Brian S J
Department of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas 66045-7582, USA.
J Med Chem. 2008 Oct 23;51(20):6495-502. doi: 10.1021/jm8007486. Epub 2008 Sep 25.
Gedunin (1), a tetranortriterpenoid isolated from the Indian neem tree ( Azadirachta indica), was recently shown to manifest anticancer activity via inhibition of the 90 kDa heat shock protein (Hsp90) folding machinery and to induce the degradation of Hsp90-dependent client proteins similar to other Hsp90 inhibitors. The mechanism of action by which gedunin induces client protein degradation remains undetermined, however, prior studies have demonstrated that it does not bind competitively versus ATP. In an effort to further probe the mechanism of action, 19 semisynthetic derivatives of gedunin were prepared and their antiproliferative activity against MCF-7 and SkBr3 breast cancer cells determined. Although no compound was found to exhibit antiproliferative activity more effective than the natural product, functionalities critical for antiproliferative activity have been identified.
格杜宁(1)是从印度楝树(印楝)中分离出的一种四降三萜类化合物,最近研究表明,它通过抑制90 kDa热休克蛋白(Hsp90)折叠机制表现出抗癌活性,并能诱导Hsp90依赖的客户蛋白降解,这与其他Hsp90抑制剂类似。然而,格杜宁诱导客户蛋白降解的作用机制尚不清楚,此前的研究表明,它与ATP不存在竞争性结合。为了进一步探究其作用机制,制备了19种格杜宁的半合成衍生物,并测定了它们对MCF-7和SkBr3乳腺癌细胞的抗增殖活性。虽然没有发现哪种化合物的抗增殖活性比天然产物更有效,但已确定了抗增殖活性的关键功能基团。